{"slug":"takeda-pharmaceutical","name":"다케다약품","name_en":"Takeda Pharmaceutical","ticker":"4502.T","updated_at":"2026-07-11T10:21:18.865+00:00","canonical":"https://valuechain.wiki/takeda-pharmaceutical","kicker":"닛케이 225","kicker_en":"Nikkei 225","lead":"소화기와 희귀질환 치료제를 개발하는 일본 최대의 제약 기업이다. 닛케이 225 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"Japan's largest pharmaceutical company, developing gastrointestinal and rare-disease treatments. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"의약품"}],"total":"약 ¥4.5조 (FY2024)"},"segments_en":{"parts":[{"name":"Pharmaceuticals"}],"total":"~¥4.5T (FY2024)"},"returns_yearly":{"2021":-5.8,"2022":29.2,"2023":11.1,"2024":0.9,"2025":30.2,"2026":4},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}